“Scientists from Germany’s Jülich Research Centre are reporting successful results from the first phase of human clinical testing of a new Alzheimer’s drug. Following promising animal experiments the drug has initially now proved safe in human subjects and will soon move into Phase II clinical trials testing efficacy.

Pin It on Pinterest

Share This